AFA
LLY icon

Arlington Financial Advisors’s Eli Lilly LLY Stock Holding History

Arlington Financial Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Hold
508
– – 0.07% 64
2025
Q4 		$546K Hold
508
– – 0.08% 61
2025
Q3 		$388K Hold
508
– – 0.06% 73
2025
Q2 		$396K Sell
508
-142
-22% -$110K 0.06% 60
2025
Q1 		$537K Buy
650
+142
+28% +$118K 0.09% 73
2024
Q4 		$392K Buy
508
+75
+17% +$62.1K 0.08% 69
2024
Q3 		$384K Hold
433
– – 0.08% 57
2024
Q2 		$392K Hold
433
– – 0.09% 56
2024
Q1 		$337K Buy
433
+67
+18% +$47.7K 0.07% 62
2023
Q4 		$213K Buy
+366
New +$214K 0.06% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arlington Financial Advisors's LLY Position: Q1 2026 in Review

Arlington Financial Advisors held its Eli Lilly (LLY) position steady in Q1 2026 at 508 shares worth $467K. The position accounts for 0.07% of the portfolio, ranked #64.

Arlington Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $546K in Q4 2025. 4,351 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Arlington Financial Advisors held 508 shares of Eli Lilly worth $467K as of Q1 2026.
  • Arlington Financial Advisors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.07% of Arlington Financial Advisors's portfolio in Q1 2026, its #64 holding.
  • Arlington Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Arlington Financial Advisors's Eli Lilly position peaked at $546K in Q4 2025.
  • 4,351 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Arlington Financial Advisors's 13F filing for Q1 2026, filed 15 Apr 2026.